InvestorsHub Logo
Followers 98
Posts 15870
Boards Moderated 0
Alias Born 09/13/2012

Re: janice shell post# 5129

Tuesday, 05/23/2017 4:59:18 AM

Tuesday, May 23, 2017 4:59:18 AM

Post# of 14668
It's not a toxic convertible note Janice. Northbridge doesn't get more shares to sell the cheaper the share price gets. They got 140M shares period.

$724,108.50 / 140M shares = .0051


It's not in NB's interest to kill the share price below .0051

He wanted to make money. Why would he think the stock price would go up?



On May 9, 2017, EastGate Biotech Corp. (the “Company”) entered into a Settlement Agreement with Northbridge Financial, Inc. (“Northbridge”), whereby Northbridge acquired liabilities of the Company in the amount of $724,108.50 (the “Debt”), which was owed by the Company to third parties related to debts related to the Company’s outstanding liabilities. The Company and Northbridge then entered into an Order Granting Approval of the Settlement Agreement, and Northbridge converted the Debt pursuant to a 3(a)(10) exemption into 140,000,000 shares of the Company’s common stock.



Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.